William Conkling - 02 Jun 2025 Form 4 Insider Report for Protara Therapeutics, Inc. (TARA)

Role: Chief Commercial Officer
Signature: /s/ William Conkling
Issuer symbol: TARA
Transactions as of: 02 Jun 2025
Net transactions value: $0
Form type: 4
Filing time: 04 Jun 2025, 16:10:26 UTC
Previous filing: 24 Apr 2025
Next filing: 21 Jan 2026
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
CONKLING WILLIAM	Chief Commercial Officer	C/O PROTARA THERAPEUTICS, INC., 345 PARK AVENUE SOUTH, 3RD FLOOR, NEWARK	/s/ William Conkling	04 Jun 2025	0001852018

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	TARA	Common Stock	Award	$0	+50,000		$0.000000	50,000	02 Jun 2025	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	TARA	Stock Option (Right to Buy)	Award	$0	+200,000		$0.000000	200,000	02 Jun 2025	Common Stock	200,000	$3.30	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The shares being reported are being issued pursuant to restricted stock unit awards (RSUs), each of which represents a contingent right to receive one share of Issuer's common stock. The RSUs vest in equal one third installments on the first, second and third anniversaries of June 2, 2025.
F2	25% of the shares vest on the one year anniversary of June 2, 2025 and 1/48th of the shares vest monthly thereafter over the next three years, subject to the Reporting Person's continuous service with the Issuer as of each such date.